HIV Drug's weight gain mystery: study tracks moms and babies
NCT ID NCT04991402
First seen Feb 20, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study followed about 1,900 pregnant women (some with HIV, some without) and their children for two years to see how HIV and the drug dolutegravir affect weight gain and body fat. Researchers measured things like weight, metabolism, and blood markers in both mothers and babies. The goal was to understand if HIV or its treatment leads to unhealthy weight changes during and after pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gugulethu Community Health Center
Cape Town, South Africa
-
Mitchell's Plain Community Health Center
Cape Town, South Africa
Conditions
Explore the condition pages connected to this study.